CD8A and neoplasm: In this study, we tested the prognostic value of CD8 cell densities quantified by DIA in the tumor and stroma compartments and applied a recently proposed method, based on hexagonal grid analytics of the DIA data to compute CD8 local density profiles (Immunogradient) across automatically detected tumor–stroma IZ (86).